Search Results
May 11, 2026, 06:00 ET Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
detect gene fusions such as NRG1 and ensure patients are appropriately identified for targeted therapy."— James Cleary, MD, PhD, Director of Clinical Research, Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard
More news about: Partner Therapeutics, Inc.
May 11, 2026, 04:03 ET India struggles with a quit success rate under 5%: Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg
where cessation infrastructure is still developing and behavioural support alone may not be sufficient for many users.Dr. Karl Fagerström, PhD, Professor Emeritus and Deputy Editor of Nicotine & Tobacco Research, said, "India's policy framework already recognizes that nicotine replacement
More news about: The Asian Coalition for Health Empowerment (ACHE)
May 09, 2026, 16:05 ET NIRSense Supports the US Army in the Indo-Pacific with Tissue Oxygenation Assessment for Battlefield Casualty Care at Balikatan-26
realistic training environment and demonstrate how tissue oxygenation monitoring can help inform battlefield casualty assessment," said Robert Furberg, PhD, TP-C of NIRSense. "Our goal is to equip combat medics with actionable data that goes beyond standard vital signs alone and supports earlier recognition
More news about: NIRSense, Inc.
May 09, 2026, 15:21 ET AAVnerGene anuncia AAVone®2.1, plataforma de produção de AAV de última geração com plasmídeo único que atinge carca de 1e16 GC/L e mais de 70% de capsídeos completos na coleta
de comercialização, com custo de fabricação, qualidade do vetor e escalabilidade do processo entre os entraves mais críticos", disse Daozhan Yu, PhD, CEO da AAVnerGene. "A AAVone®2.1 tem o potencial de tornar a fabricação de AAV mais simples, escalável e econômica, contribuindo para
More news about: AAVnerGene Inc.
May 09, 2026, 15:08 ET AAVnerGene kündigt AAVone®2.1 an, eine Einzelplasmid-AAV-Produktionsplattform der nächsten Generation, die ~1e16 GC/L und >70 % volle Kapside bei der Ernte erreicht
Kommerzialisierung, wobei die Herstellungskosten, die Vektorqualität und die Skalierbarkeit des Prozesses zu den kritischsten Faktoren gehören", sagte Daozhan Yu, PhD, Chief Executive Officer von AAVnerGene. „AAVone®2.1 hat das Potenzial, die AAV-Herstellung einfacher, skalierbarer und kosteneffizienter
More news about: AAVnerGene Inc.
May 08, 2026, 16:05 ET Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
David Spetzler, MS, PhD, MBA, President of Caris Life Sciences. "This submission of Caris Assure for review through the New York State Department of Health's Wadsworth Center
More news about: Caris Life Sciences
May 08, 2026, 13:48 ET Basata Raises $21M Series A to Rebuild the $1T Operational Layer of American Healthcare
Co-founder Chetan, a former principal engineer at Medtronic, watched his wife wait months to see a cardiologist. Co-founder Vivin, a Computer Science PhD, saw his wife endure the same broken referral process.That conviction shapes how the company builds. "Our Forward-Deployed Engineer returned from
More news about: Basata
May 08, 2026, 12:49 ET The Inner Circle acknowledges Ruth L. Miller, PhD, DD as a Pinnacle Professional Member Inner Circle of Excellence
Prominently featured in The Inner Circle, Ruth L. Miller, PhD, DD is recognized as a Pinnacle Professional Member Inner Circle of Excellence for her contributions as a Systems Scientist and Futurist advancing Consciousness Studies. Ruth L. Miller, PhD, DD, has been incorporating the study of consciousness
More news about: The Inner Circle
May 08, 2026, 11:00 ET INSEAD welcomes inaugural GEMBA Flex cohort, marking a new era of flexible executive learning
Executive Master in Change) and PhD programmes. In addition, more than 18,000 executives participate in INSEAD
More news about: INSEAD
May 08, 2026, 10:30 ET Journal of Emergency Nursing Examines Barriers to Infection Control in ED
Equipment: Perspectives on Infection Prevention and Control from Emergency Department Health Care Personnel," highlights what JEN editor Anna Valdez, PhD, RN, PHN, CEN, CFRN, FAEN, FAADN, FADLN, called "a critical reality in emergency care." "Nurses are consistently exposed to infectious diseases,
More news about: Emergency Nurses Association
May 08, 2026, 10:05 ET MountAIn disrupts Edge AI landscape to Deliver Cloud-Grade Computer Vision Stack on Alif Semiconductor's Ensemble and Balletto Processors
has been forced to choose between expensive, power-hungry MPUs and cost-efficient MCUs" said Vincent Huard, CEO of MountAIn. "We believe that 'Embedded AI' shouldn't require a PhD in firmware optimization. We are on a mission to Deliver cloud-grade vision at MCU economics and to unlock entirely new use cases.""To truly democratize Edge AI and scale
More news about: MountAIn; Alif Semiconductor
May 08, 2026, 09:30 ET Enhanced Group CEO, Maximilian Martin, Issues Letter to Shareholders
experts including world renowned sports-cardiologist Prof. Dr. Guido Pieles and one of the world's leading sports integrity experts Michael Ashenden, PhD, JD. A few things worth noting about the program:Each athlete's protocol is personalized along two dimensions: who they are as
More news about: Enhanced
May 08, 2026, 08:17 ET AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
commercialization challenges, with manufacturing cost, vector quality, and process scalability among the most critical constraints," said Daozhan Yu, PhD, Chief Executive Officer of AAVnerGene. "AAVone®2.1 has the potential to make AAV manufacturing simpler, more scalable, and more cost-efficient,
More news about: AAVnerGene Inc.
May 08, 2026, 07:57 ET AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
commercialization challenges, with manufacturing cost, vector quality, and process scalability among the most critical constraints," said Daozhan Yu, PhD, Chief Executive Officer of AAVnerGene. "AAVone®2.1 has the potential to make AAV manufacturing simpler, more scalable, and more cost-efficient,
More news about: AAVnerGene Inc.
May 08, 2026, 07:30 ET Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
disappointed with the unanticipated outcome of the FLASH2 (Fluorescent Light Activated Synthetic Hypericin 2) study," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "Despite the fact that HyBryte™ (synthetic hypericin) demonstrated statistically significant reductions
More news about: SOLIGENIX, INC.
May 08, 2026, 05:08 ET Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
development," says Christer Nordstedt, CEO of Oblique Therapeutics.For further information, please contactChrister Nordstedt MD PhDCEOOblique Therapeutics ABBox 40091-9037Datavägen 15D436 32 AskimMobil: +46 70 251
More news about: Oblique Therapeutics AB
May 08, 2026, 05:01 ET Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor
development," says Christer Nordstedt, CEO of Oblique Therapeutics.For further information, please contactChrister Nordstedt MD PhDCEOOblique Therapeutics ABBox 40091-9037Datavägen 15D436 32 AskimMobil: +46 70 251
More news about: Oblique Therapeutics AB
May 07, 2026, 19:18 ET LiT Biosciences, LLC Launches Patent-Pending LiT Protect, a Scientist-Founded Botanical Dietary Supplement for Everyday Wellness
Co-founded by Albert P. Li, PhD, and Travis Denton, PhD, the Spokane-based life sciences company brings deep expertise in toxicology, human metabolism, medicinal chemistry and nicotine biochemistry to botanical product development.SPOKANE,
More news about: LiT Biosciences, LLC
May 07, 2026, 15:15 ET Schools of Nursing See Enrollment Increases Across Most Program Levels, Signaling Strong Interest in Nursing Careers
at 452 schools of nursing across the U.S.Last year, enrollment in PhD nursing programs declined for the 11th consecutive year, with a 3.05% decrease (127 students) from 2024 to 2025. Since 2013, enrollment in PhD programs has decreased by 26.2%, from 5,145 to 4,077 students. This downward
More news about: American Association of Colleges of Nursing
May 07, 2026, 14:02 ET RIVANNA receives FDA 510(k) clearance for Accuro XV musculoskeletal ultrasound imaging system
spanning eight academic medical centers nationwide."FDA clearance of the Accuro XV marks a major inflection point for RIVANNA," said Will Mauldin, PhD, Co-founder and CEO. "This clearance demonstrates the scalability of our core platform — shared AI architecture, imaging hardware, and regulatory pathway
More news about: RIVANNA
May 07, 2026, 14:01 ET The Inner Circle acknowledges Asia Alexus Alexander as a Pinnacle Professional of The Year
marketing from Southern University in 2022 and a Master of Science in marketing from East Texas A&M University in 2024. She is currently pursuing a PhD in business administration with a concentration in marketing at the University of South Alabama, with plans to complete her doctoral studies in 2028.Before
More news about: The Inner Circle
May 07, 2026, 13:00 ET Why You Don't Feel Loved (Even When You Are)
author Lisa Feldman Barrett, PhD, neuroscientist and NYU Dean Wendy Suzuki, PhD, futures designer Nick Foster, RDI, sleep psychologist Jade Wu, PhD, broadcaster and author Krista Tippett, journalist and author Eliot Stein, medical anthropologist and author Theresa MacPhail, PhD, and poet, activist, and author
More news about: Unlikely Collaborators
May 07, 2026, 12:26 ET New Nature Scientific Reports Study Challenges the Inevitability of Cognitive Decline and Proves Brain Gain is Possible at Any Age
under the outdated notion that we need to wait until something bad happens to our brain before we do anything for it," said Sandra Bond Chapman, PhD, chief director of Center for BrainHealth and distinguished professor at UT Dallas. "This study reminds us that our brain is not defined by age,
More news about: Center for BrainHealth
May 07, 2026, 12:09 ET Drill Program is Underway at VR's New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada
this document, and on the Company's website, has been reviewed and approved on behalf of the Company by the President & CEO, Dr. Michael Gunning, PhD, P.Geo., a non-independent Qualified Person.ABOUT VR RESOURCES LTD.VR is an established junior exploration company based in Vancouver.
More news about: VR Resources Limited
May 07, 2026, 11:15 ET ACLM Announces 2026 Lifestyle Medicine Annual Conference Focused on Health Restoration and Care Transformation
Mussallem, DO, DipABLM, global chief medical officer at Fountain LifeJudson Brewer, MD, PhD, director of Research and Innovation at the Mindfulness Center at Brown UniversityValter Longo, PhD, director of the Longevity Institute at the University of Southern California–Leonard Davis School
More news about: American College of Lifestyle Medicine